Back

Clonal haematopoiesis and cardiovascular disease: how low can you go?

European Heart Journal

12 December 2020
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Abstract

Abstract

Contributors

Megan A Evans
Megan A Evans

Author

Soichi Sano
Soichi Sano

Author

Kenneth Walsh
Kenneth Walsh

Author

University of Virginia Charlottesville , United States of America

You may be interested in
thumbnail
Congress Presentation
Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size
26 August 2023
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression
25 August 2023
thumbnail
Congress Presentation
Combined CD34⁺ cell frequency and S100A8/A9 profiling improves biological risk stratification in peripheral and carotid atherosclerosis
30 August 2026
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential (CHIP) is associated with disease progression and increased mortality in aortic valve stenosis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources